ClinConnect ClinConnect Logo
Search / Trial NCT03057821

Propionibacterium Acnes in Shoulder Arthroplasty

Launched by UNIVERSITY OF UTAH · Feb 15, 2017

Trial Information

Current as of June 06, 2025

Completed

Keywords

Hydrogen Peroxide Propionibacterium Acnes Shoulder Arthroplasty

ClinConnect Summary

Over half of all post-operative infections after shoulder arthroplasty are due to Propionibacterium acnes. Even in apparently "aseptic" revisions, nearly all cultures taken at the time of revision surgery are positive for P acnes, and thus low-grade infection with this bacteria may be a more common cause of failure than previously suspected. Current antibiotic prophylaxis methods are ineffective against P acnes. Despite intravenous cefazolin, P acnes can be cultured from the glenohumeral joint in 42% of patients undergoing primary total shoulder arthroplasty. Despite skin preparation with c...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing primary shoulder arthroplasty
  • Exclusion Criteria:
  • Patients with prior shoulder surgery.
  • Patients with a symptomatic infection or history of infection, recent antibiotic use (within six weeks), or with clinical signs of infection such as an elevated ESR, CRP, positive aspiration cultures, or positive biopsy.
  • Patients with a known hypersensitivity to hydrogen peroxide.

About University Of Utah

The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.

Locations

Salt Lake City, Utah, United States

Patients applied

0 patients applied

Trial Officials

Peter Chalmers, MD

Principal Investigator

University of Utah

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials